Therapy Areas: Respiratory
16 May 2025 - Shanghai Ark Biopharmaceutical Co Ltd ('ArkBio') on Thursday reported positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treating idiopathic pu...
14 May 2025 - Software as a Medical Device (SaMD) developer Median Technologies (Euronext Growth Paris:ALMDT) has submitted a 510(k) application to the US Food and Drug Administration for eyonis LCS, ...
14 May 2025 - Cumberland Pharmaceuticals Inc (Nasdaq: CPIX), a US-based specialty pharmaceutical company with development efforts focused on new products for rare diseases, announced on Tuesay a partn...
12 May 2025 - Chinese late-stage clinical biopharmaceutical company Minghui Pharmaceutical announced on Friday an exclusive licensing and collaboration agreement with Qilu Pharmaceutical for the devel...
7 May 2025 - British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) on Wednesday announced positive...
6 May 2025 - Phanes Therapeutics Inc, a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced on Monday that the first patient has been dosed in th...